TSXV:LOVEPersonal Products
Cannara Biotech (TSXV:LOVE) Q1 EPS Drop Tests Bullish Earnings Growth Narrative
Cannara Biotech (TSXV:LOVE) has opened Q1 2026 with total revenue of C$30.1 million and basic EPS of C$0.011, coming off a trailing twelve month period where revenue reached C$112.2 million and EPS stood at C$0.129. Over recent quarters the company has seen revenue move from C$24.95 million in Q1 2025 to C$30.11 million in Q1 2026, while basic EPS has ranged from C$0.0256 to C$0.0453 through 2025 before landing at C$0.011 this quarter. This sets up a results season in which investors are...